Xcout Intel
Curve Therapeutics
Curve Therapeutics is a private biotechnology company headquartered in Southampton, United Kingdom, pioneering a revolutionary proprietary microcycle drug discovery platform to address challenging intracellular targets.
Subscribe to see Curve Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Curve Therapeutics at a glance
Curve Therapeutics is a life sciences company headquartered in United Kingdom. Its most recent funding round, seed, raised $51.2M in February 2024. Xcout tracks 12 named people at Curve Therapeutics, including Simon Jones (Chief Financial Officer and Chief Operating Officer).
Curve Therapeutics leadership
- Simon JonesChief Financial Officer and Chief Operating Officer
- Dr Rab PrinjhaChief R D Officer
- Dr Richard RathmellVice President of Chemistry
- Dr Rob JeprasVice President of Screening
- Dr Sally PriceVice President of Biology
- Dr Cora GriffinHead of Business Development
6 more named people on record for Curve Therapeutics, with roles, board committees and tenure — see the full roster →
Curve Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| seed | $51.2M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Curve Therapeutics competitors
A few of Curve Therapeutics's closest competitors — see the full list of competitors and alternatives →
Cyclana Bio is a biotechnology company headquartered in Cambridge, United Kingdom, pioneering tissue-level approaches to advance drug discovery and uncover mechanisms in women's health.
Maxion Therapeutics is a biotechnology company headquartered in Cambridge, England, utilizing proprietary KnotBody technology to discover and develop first-in-class protein therapeutics.
Constructive Bio is a biotechnology research company headquartered in Cambridge, United Kingdom, that focuses on designing and manufacturing proteins with non-canonical amino acids for new medicines and materials.
Cime Therapeutics Inc. is a chemistry-first company that provides an automated synthesis platform integrating artificial intelligence and machine learning for drug discovery. The company serves the pharmaceutical and biotechnology sectors by producing novel therapeutic molecules, such as small molecules, molecular glues, and covalent compounds, at high speed and scale.
DynamiCure Biotechnology is a life sciences company applying innovative approaches to drug discovery from its facilities in Waltham, Massachusetts.
Exo Therapeutics is a small molecule drug discovery and development biotechnology company headquartered in Cambridge, Massachusetts. The company utilizes a pioneering proprietary technology platform to unlock and address notoriously intractable pharmaceutical and disease targets.
Get Curve Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Curve Therapeutics in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access